SCHEMBL45395

SCHEMBL45395

CC1(C)CC(c2cccc(N3CCOCC3)c2)Nc2ccc(C(=O)OCC(N)=O)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
F10 P00742 7/20 0.39
F11 P03951 7/20 0.39
F7 P08709 7/20 0.39
CYP2C19 P33261 1/20 0.38
USP2 O75604 1/20 0.37
GAA P10253 1/20 0.37
CYP3A4 P08684 1/20 0.36
KMO O15229 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
PLOD2 O00469 1/20 0.35
PLOD3 O60568 1/20 0.35
PLOD1 Q02809 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL45258 0.90 F11 (0.37) ALDH1A1F10F11F7CYP2C19
SCHEMBL45015 0.89 MAPT (0.40) ALDH1A1TDP1USP2GAASIRT2
SCHEMBL45781 0.88 F10 (0.45) ALDH1A1F10F11F7CYP2C19
SCHEMBL11025709 0.88 F7 (0.44) ALDH1A1F10F11F7CYP2C19
SCHEMBL11026479 0.86 CYP2C19 (0.41) ALDH1A1F10F11F7CYP2C19
SCHEMBL41549 0.85 KMO (0.52) ALDH1A1F10F11F7CYP2C19
SCHEMBL45198 0.84 PRKAG1 (0.47) ALDH1A1CYP2C19USP2GAACYP3A4
SCHEMBL11026483 0.83 F10 (0.45) ALDH1A1F10F11F7CYP2C19
SCHEMBL45312 0.82 F10 (0.47) ALDH1A1F10F11F7CYP2C19
SCHEMBL11025215 0.81 MRGPRX4 (0.43) ALDH1A1F10F11F7CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004218-A1 NOVEL TETRAHYDRO-QUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004218-A1 NOVEL TETRAHYDRO-QUINOLINE DERIVATIVES GPR119, PRKAB1, PRKAG1 ALDH1A1 361/4885TDP1 1040/4885F10 2676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.